I-Min Lee1, Eric J Shiroma. 1. Division of Preventive Medicine, Department of Epidemiology, Brigham & Women's Hospital, Harvard Medical School, Harvard School of Public Health, , Boston, Massachusetts USA.
Abstract
BACKGROUND: The current guidelines for aerobic activity require that adults carry out ≥150 min/week of moderate-intensity physical activity, with a large body of epidemiological evidence showing this level of activity to decrease the incidence of many chronic diseases. Less is known about whether light-intensity activities also have such benefits, and whether sedentary behaviour is an independent predictor of increased risks of these chronic diseases, as imprecise assessments of these behaviours and cross-sectional study designs have limited knowledge to date. METHODS: Recent technological advances in assessment methods have made the use of movement sensors, such as the accelerometer, feasible for use in longitudinal, large-scale epidemiological studies. Several such studies are collecting sensor-assessed, objective measures of physical activity with the aim of relating these to the development of clinical endpoints. This is a relatively new area of research; thus, in this article, we use the Women's Health Study (WHS) as a case study to illustrate the challenges related to data collection, data processing and analyses of the vast amount of data collected. RESULTS: The WHS plans to collect 7 days of accelerometer-assessed physical activity and sedentary behaviour in ~18 000 women aged ≥62 years. Several logistical challenges exist in collecting data; nonetheless, as of 31 August 2013, 11 590 women have already provided some data. In addition, the WHS experience on data reduction and data analyses can help inform other similar large-scale epidemiological studies. CONCLUSIONS: Important data on the health effects of light-intensity activity and sedentary behaviour will emerge from large-scale epidemiological studies collecting objective assessments of these behaviours.
BACKGROUND: The current guidelines for aerobic activity require that adults carry out ≥150 min/week of moderate-intensity physical activity, with a large body of epidemiological evidence showing this level of activity to decrease the incidence of many chronic diseases. Less is known about whether light-intensity activities also have such benefits, and whether sedentary behaviour is an independent predictor of increased risks of these chronic diseases, as imprecise assessments of these behaviours and cross-sectional study designs have limited knowledge to date. METHODS: Recent technological advances in assessment methods have made the use of movement sensors, such as the accelerometer, feasible for use in longitudinal, large-scale epidemiological studies. Several such studies are collecting sensor-assessed, objective measures of physical activity with the aim of relating these to the development of clinical endpoints. This is a relatively new area of research; thus, in this article, we use the Women's Health Study (WHS) as a case study to illustrate the challenges related to data collection, data processing and analyses of the vast amount of data collected. RESULTS: The WHS plans to collect 7 days of accelerometer-assessed physical activity and sedentary behaviour in ~18 000 women aged ≥62 years. Several logistical challenges exist in collecting data; nonetheless, as of 31 August 2013, 11 590 women have already provided some data. In addition, the WHS experience on data reduction and data analyses can help inform other similar large-scale epidemiological studies. CONCLUSIONS: Important data on the health effects of light-intensity activity and sedentary behaviour will emerge from large-scale epidemiological studies collecting objective assessments of these behaviours.
Authors: Darren Er Warburton; Sarah Charlesworth; Adam Ivey; Lindsay Nettlefold; Shannon Sd Bredin Journal: Int J Behav Nutr Phys Act Date: 2010-05-11 Impact factor: 6.457
Authors: David W Dunstan; Jo Salmon; Neville Owen; Timothy Armstrong; Paul Z Zimmet; Timothy A Welborn; Adrian J Cameron; Terence Dwyer; Damien Jolley; Jonathan E Shaw Journal: Diabetes Care Date: 2004-11 Impact factor: 19.112
Authors: Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell Journal: Med Sci Sports Exerc Date: 2008-01 Impact factor: 5.411
Authors: I-Min Lee; Eric J Shiroma; Felipe Lobelo; Pekka Puska; Steven N Blair; Peter T Katzmarzyk Journal: Lancet Date: 2012-07-21 Impact factor: 79.321
Authors: Shao-Hsien Liu; Charles B Eaton; Jeffrey B Driban; Timothy E McAlindon; Kate L Lapane Journal: Rheumatol Int Date: 2016-07-19 Impact factor: 2.631
Authors: Chirag J Patel; Jacqueline Kerr; Duncan C Thomas; Bhramar Mukherjee; Beate Ritz; Nilanjan Chatterjee; Marta Jankowska; Juliette Madan; Margaret R Karagas; Kimberly A McAllister; Leah E Mechanic; M Daniele Fallin; Christine Ladd-Acosta; Ian A Blair; Susan L Teitelbaum; Christopher I Amos Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-07-14 Impact factor: 4.254
Authors: Peter James; Jaime E Hart; J Aaron Hipp; Jonathan A Mitchell; Jacqueline Kerr; Philip M Hurvitz; Karen Glanz; Francine Laden Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-02-14 Impact factor: 4.254
Authors: Steven P Hooker; Brent Hutto; Wenfei Zhu; Steven N Blair; Natalie Colabianchi; John E Vena; David Rhodes; Virginia J Howard Journal: J Sci Med Sport Date: 2015-04-17 Impact factor: 4.319
Authors: Christine A Pellegrini; Sara M Powell; Nicholas Mook; Katherine DeVivo; Linda Ehrlich-Jones Journal: Curr Rheumatol Rep Date: 2018-10-06 Impact factor: 4.592
Authors: Sarah Kozey Keadle; Eric J Shiroma; Masamitsu Kamada; Charles E Matthews; Tamara B Harris; I-Min Lee Journal: Am J Prev Med Date: 2017-01-03 Impact factor: 5.043
Authors: Ruby Fore; Jaime E Hart; Christine Choirat; Jennifer W Thompson; Kathleen Lynch; Francine Laden; Jorge E Chavarro; Peter James Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-02-25 Impact factor: 4.254